Previous Article | Next Article ![]()
Infect Immun, August 1998, p. 3841-3847, Vol. 66, No. 8
Department of Medical Microbiology and
Hygiene, University of Ulm Clinic, 89081 Ulm, Germany
Received 8 January 1998/Returned for modification 9 April
1998/Accepted 4 May 1998
Many of the virulence factors associated with fulminant group A
streptococci (GAS) infection are expressed under in vitro exponential
growth conditions. However, the survival of GAS in tissue and
intracellularly, as well as colonization of asymptomatic carriers, has
been reported for GAS. The bacteria associated with these niches may
encounter high-density, low-nutrient-flowthrough conditions that may
more closely mimic in vitro stationary-phase conditions than
exponential growth. Therefore, the behavior of GAS in stationary-phase
culture was examined. We observed that after 24 h in stationary
phase, GAS serotypes M49 and M2 developed a unstable
colony dimorphism of typical large and atypical small colonies. Between
days 4 and 5, we isolated stabilized atypical small colonies which
remained stable for up to nine passages (approximately 200 generations)
on fresh medium before fully reverting to the large-colony phenotype.
Upon analysis, the small colonies showed no difference in cell number
per colony, growth rate, survival in prolonged stationary-phase
culture, or antibiotic sensitivity. However, the small colonies
showed decreased transcription of hyaluronic acid capsule, the global
positive virulence factor regulator gene mga, the
mga-regulated emm mRNA (M-protein structural gene), and speB (cysteine protease). Accordingly, the small
colonies were completely sensitive in a traditional phagocytosis
assay. The production of virulence factors and phagocytosis resistance of the small-colony isolates was recovered when, after several passages
on fresh medium, the colony morphology began to revert.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Production of Stabilized Virulence Factor-Negative
Variants by Group A Streptococci during Stationary Phase

*
Corresponding author. Mailing address: Department of
Medical Microbiology and Hygiene, University of Ulm Clinic, Robert-Koch Str. 8, 89081 Ulm, Germany. Phone: 49-731-5024615. Fax: 49-731-5024619. E-mail: andreas.podbielski{at}medizin.uni-ulm.de.
Present address: Temple University School of Medicine, Department
of Microbiology and Immunology, Philadelphia, PA 19140.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|